FRANKLIN LAKES, N.J., April 13, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its BD MAX™ Molecular Multi-Drug ...
FRANKLIN LAKES, N.J., Dec. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of its respiratory and ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics portfolio in Europe. This follows the ...
Becton Dickinson’s Diagnostics operation received FDA clearance to market the BD MAX™ MRSA molecular test. The assay is carried out on the automated BD MAX system, and is designed to rapidly identify ...
BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the availability of the FDA-cleared BD MAX™ Enteric Bacterial ...
BD MAX SYSTEM for BD MAX MRSA assay by Becton Dickinson BD Diagnostics announced that it has received FDA approval to market BD MAX MRSA molecular test, a new test that is designed to rapidly and ...
This briefing describes the regulated use of the technology for the indication specified, in the setting described, and with any other specific equipment referred to. It is the responsibility of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results